This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?
Great to have First Author, Jessica Tangren join us!
Anna Burgner made her debut hosting the American Chat, and Ben did a great job as always with the EU version
New rule for visual abstract. We need to stop adding the logo of the publishing journal. Replace the logo with the authors name. So here is the latest visual abstract in the new style.
